Literature DB >> 17207896

Neuropeptide Y regulates catecholamine release evoked by interleukin-1beta in mouse chromaffin cells.

Joana Rosmaninho-Salgado1, Ana Rita Alvaro, Eric Grouzmann, Emilia P Duarte, Cláudia Cavadas.   

Abstract

Activation of the hypothalamic-pituitary-adrenal gland (HPA) axis can modulate the immune system. Cytokines and neuropeptide Y (NPY) are potent regulators of the HPA axis and are both produced by the adrenal medulla. The cytokine interleukin-1beta (IL-1beta) belongs to the interleukin-1 family along with interleukin-1alpha and the interleukin receptor antagonist (IL-1ra). The aim of the present study was to determine the interaction between NPY and IL-1beta in catecholamine (norepinephrine, NE and epinephrine, EP) release from mouse chromaffin cells in culture. We found that IL-1beta increased the constitutive release of NPY, NE and EP from mouse chromaffin cells. This IL-1beta stimulatory effect was blocked by IL-1ra. The immunoneutralization of NPY and the use of the NPY Y(1) receptor antagonist (BIBP 3226) inhibited the stimulatory effect of IL-1beta on catecholamine release from these cells. The present work shows that IL-1beta induces catecholamine release, and in turn this peptide will induce an additional increase in catecholamine release acting through the Y(1) receptor. This work suggests that NPY is involved in the regulatory loop between the immune and the adrenal system in some pathophysiological conditions where plasmatic IL-1beta increases, like in sepsis, rheumatoid arthritis, stress or hypertension.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17207896     DOI: 10.1016/j.peptides.2006.11.015

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  9 in total

Review 1.  Cytokine interactions with adrenal medullary chromaffin cells.

Authors:  Shirley A Douglas; Dharshini Sreenivasan; Fiona H Carman; Stephen J Bunn
Journal:  Cell Mol Neurobiol       Date:  2010-11-19       Impact factor: 5.046

2.  Interleukin-6-mediated signaling in adrenal medullary chromaffin cells.

Authors:  Danielle E Jenkins; Dharshini Sreenivasan; Fiona Carman; Babru Samal; Lee E Eiden; Stephen J Bunn
Journal:  J Neurochem       Date:  2016-12-05       Impact factor: 5.372

Review 3.  Immune-neuroendocrine integration at the adrenal gland: cytokine control of the adrenomedullary transcriptome.

Authors:  Stephen J Bunn; Djida Ait-Ali; Lee E Eiden
Journal:  J Mol Neurosci       Date:  2012-03-16       Impact factor: 3.444

4.  Neuropeptide Y (NPY): genetic variation in the human promoter alters glucocorticoid signaling, yielding increased NPY secretion and stress responses.

Authors:  Kuixing Zhang; Fangwen Rao; Jose Pablo Miramontes-Gonzalez; C Makena Hightower; Brian Vaught; Yuhong Chen; Tiffany A Greenwood; Andrew J Schork; Lei Wang; Manjula Mahata; Mats Stridsberg; Srikrishna Khandrika; Nilima Biswas; Maple M Fung; Jill Waalen; Rita P Middelberg; Andrew C Heath; Grant W Montgomery; Nicholas G Martin; John B Whitfield; Dewleen G Baker; Nicholas J Schork; Caroline M Nievergelt; Daniel T O'Connor
Journal:  J Am Coll Cardiol       Date:  2012-09-26       Impact factor: 24.094

5.  Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study.

Authors:  Maria Baltazi; Niki Katsiki; Christos Savopoulos; Fotios Iliadis; George Koliakos; Apostolos I Hatzitolios
Journal:  Am J Cardiovasc Dis       Date:  2011-05-20

6.  Differential activation of enkephalin, galanin, somatostatin, NPY, and VIP neuropeptide production by stimulators of protein kinases A and C in neuroendocrine chromaffin cells.

Authors:  Vivian Hook; Thomas Toneff; Sheley Baylon; Catherine Sei
Journal:  Neuropeptides       Date:  2008-07-10       Impact factor: 3.286

Review 7.  The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour.

Authors:  A Farzi; F Reichmann; P Holzer
Journal:  Acta Physiol (Oxf)       Date:  2015-01-09       Impact factor: 6.311

8.  Decreased plasma Chromogranin A361-372 (Catestatin) but not Chromogranin A17-38 (Vasostatin) in female dogs with bacterial uterine infection (pyometra).

Authors:  Supranee Jitpean; Mats Stridsberg; Ann Pettersson; Odd V Höglund; Bodil Ström Holst; Ragnvi Hagman
Journal:  BMC Vet Res       Date:  2015-01-31       Impact factor: 2.741

Review 9.  Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis.

Authors:  Collin J Byrne; Sandhya Khurana; Aseem Kumar; T C Tai
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-28       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.